ArticleCureus2025
Esophageal Dieulafoy's Lesion: A Rare and Life-Threatening Cause of Massive Upper Gastrointestinal Bleeding Successfully Treated With Argon Plasma Coagulation.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dieulafoy's lesion is a rare but potentially life-threatening cause of upper gastrointestinal (UGI) bleeding. It is characterized by an abnormally large, tortuous artery in the submucosa that can erode the overlying mucosa and cause sudden, severe hemorrhage. While commonly found in the stomach, Dieulafoy's lesions in the esophagus are extremely rare and pose a diagnostic and therapeutic challenge. We report the case of a 23-year-old female with cerebral palsy, maintained on valproate and baclofen, who presented with multiple episodes of hematemesis. Laboratory findings revealed a hemoglobin level of 4 g/dL, significantly reduced from her baseline of 12 g/dL. After resuscitation with blood transfusions, the patient underwent urgent esophagogastroduodenoscopy, which identified an actively bleeding Dieulafoy's lesion in the distal esophagus. Initial hemostatic clip placement failed, and hemostasis was successfully achieved using argon plasma coagulation (APC). The patient remained stable after the procedure and was discharged upon clinical improvement. Esophageal Dieulafoy's lesion, though rare, should be considered in severe UGI bleeding. Endoscopic hemostasis is the mainstay of treatment, and APC can be effective when other methods fail.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.